Eli Lilly’s weight loss drug Zepbound cuts heart failure risks in late-stage study – CNBC By herbalweightloss Eli Lilly’s weight loss drug Zepbound cuts heart failure risks in late-stage study CNBC Brought to you by Google News. Read the rest of the article here. Facebook Twitter Pinterest